Complementary/alternative Medicine Use among Cancer Patients in Malaysia

5 Abstract: The objective of this study was to determine the use of complementary and alternative medicine (CAM) among cancer patients in Malaysia. A cross-sectional study was carried out among cancer patients at two Malaysian referral hospitals. The questionnaire consisted of 28 items includes patients' socio-demographic characteristics, clinical characteristics and questions about CAM use. A total number of 200 cancer patients participated in this study. The majority were female, Malay, married, with tertiary education and working (54.5%, 36.5%, 53.5%, 46.5%, 45.0%; respectively). The majority were in stage 2 and diagnosed with cancer 1 to 2 years ago (47.5%, 37.5%; respectively). The prevalence of CAM used among the study participants was found to be 14%. The majority of them used the CAM during the treatment (72.7%), used the CAM less than six months (37.0%). The majority of cancer patients reported that CAM is beneficial for them and there is no side effect of CAM and they were satisfied with CAM (65.5%, 92.0%; 80.0%; respectively). Only few patients stopped conventional treatment while using CAM (14.5%). Relieve pain (19.5%) and relieve the symptoms (16.5%) were the reasons for CAM used. The most popular CAM used among cancer patients was sea cucumber (22%) and homeopathy (10.5%). The least popular CAM used reported by the study participants was green tea (0.5%). Level of education found to be significantly influence the use of CAM among cancer patients in this study. In light of the growing interest in CAM, health-care professionals need to be educated about the most common CAM therapies used among cancer patients. This study reported a new finding that 16.4% of cancer patients stopped the standard treatment while using CAM. This is a serious problem and should be addressed and further intervention studies needed.

[1]  A. Akyol,et al.  The use of complementary and alternative medicine by patients with cancer: in Turkey. , 2011, Complementary therapies in clinical practice.

[2]  Dietlind L. Wahner-Roedler,et al.  Complementary and alternative medicine: use and disclosure in radiation oncology community practice , 2011, Supportive Care in Cancer.

[3]  X. Shu,et al.  The use of complementary and alternative medicine among Chinese women with breast cancer. , 2008, Journal of alternative and complementary medicine.

[4]  Greg E. Davis,et al.  Treatment delay associated with alternative medicine use among veterans with head and neck cancer , 2006, Head & neck.

[5]  A. Jazieh,et al.  The Incidence of Potential Interactions Between Dietary Supplements and Prescription Medications in Cancer Patients at a Veterans Administration Hospital , 2006, American journal of clinical oncology.

[6]  Julia A Scott,et al.  Complementary and alternative medicine use in breast cancer patients in Europe , 2006, Supportive Care in Cancer.

[7]  G. Ozden,et al.  The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. , 2005, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[8]  J. Grutsch,et al.  The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care , 2005, Supportive Care in Cancer.

[9]  S. Verma,et al.  Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death , 2005, Breast Cancer Research and Treatment.

[10]  J. Stone,et al.  Perspectives on Complementary and Alternative Medicine , 2005 .

[11]  I. Finlay,et al.  Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. , 2003, Complementary therapies in medicine.

[12]  R. Isaacs,et al.  The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. , 2003, The New Zealand medical journal.

[13]  N. Shafiq,et al.  Patterns and perceptions of complementary and alternative medicine (CAM) among leukaemia patients visiting haematology clinic of a north Indian tertiary care hospital , 2002, Pharmacoepidemiology and drug safety.

[14]  E. Swisher,et al.  Use of complementary and alternative medicine among women with gynecologic cancers. , 2002, Gynecologic oncology.

[15]  E. Ernst The role of complementary and alternative medicine , 2000, BMJ : British Medical Journal.

[16]  A. Vickers,et al.  Prevalence of complementary therapy use by women with breast cancer. A population-based survey. , 2000, European journal of cancer.

[17]  M. Stewart,et al.  Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Singletary,et al.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  E. Guadagnoli,et al.  Use of alternative medicine by women with early-stage breast cancer. , 1999, The New England journal of medicine.

[20]  A. Maclennan,et al.  Prevalence and cost of alternative medicine in Australia , 1996, The Lancet.

[21]  Peter Fisher,et al.  Medicine in Europe: Complementary medicine in Europe , 1994 .

[22]  G. Burrows,et al.  The use of alternative therapies by children with cancer , 1994, The Medical journal of Australia.

[23]  M. Sawyer,et al.  The use of alternative therapies by children with cancer , 1994 .

[24]  M. Bennett,et al.  Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. , 2006, Oncology nursing forum.

[25]  C. Carver,et al.  Factors predicting the use of complementary therapies in a multi-ethnic sample of early-stage breast cancer patients. , 2001, Journal of the American Medical Women's Association.